DONATE

Bladder tumours reduced by 90% using nanorobots

The research, which was conducted on mice, demonstrates how these tiny nanomachines are propelled by urea present in urine and precisely target the tumour, attacking it with a radioisotope carried on their surface. Led by the IBEC and CIC biomaGUNE, the study opens the door to new, more efficient treatments for bladder cancer.

The interdisciplinarity of IBEC showcased in the opinion section of Nature Physics

Teresa Sanchis and Xavier Trepat, members of IBEC, have authored opinion pieces in the ‘World View’ section of Nature Physics. Both articles underscore IBEC’s dedication to scientific excellence, the promotion of diversity, and the cultivation of an environment conducive to collaboration. They also highlight the relevant role of IBEC at the international level in multidisciplinary research.

Researchers develop enzyme-powered micromotors based on metal-organic porous materials

In a new article published in the prestigious Journal of the American Chemical Society, researchers describe how they successfully designed and fabricated bubble-propelled enzymatic micromotors built from a highly porous metal-organic framework (MOF). These new micromotors might lead to applications for drug delivery, and adsorption of pollutants.

IBEC Seminar: Christine Horejs

Inside Nature Nanotechnology, an editor’s view Christine Horejs, Nature Nanotechnology Nature Nanotechnology was launched in October 2006 with the aim of publishing the most significant results in fundamental aspects, applications … Read more

IBEC Seminar: Christine Horejs

Inside Nature Nanotechnology, an editor’s view Christine Horejs, Nature Nanotechnology Nature Nanotechnology was launched in October 2006 with the aim of publishing the most significant results in fundamental aspects, applications … Read more

Mycobacterium in olive oil for cancer treatment

micobacterisResearchers at the Autonomous University of Barcelona (UAB) and Institute for Bioengineering of Catalonia (IBEC) have revealed a way to effectively deliver a mycobacterium needed for the treatment of bladder cancer in humans –using a formulation based on olive oil.

The researchers have found a way to reduce the natural clumping that occurs when mycobacteria cells, which possess a high content of lipids in their walls, are introduced to the usual aqueous solutions that are used for intravesical instillation in bladder cancer patients. This clumping may interfere with the interaction of the mycobacteria-host cells and negatively influence their antitumor effects.